INM | InMed Pharmaceuticals
Quick infos Headquarters: Vancouver, Canada Trade prices Volume: Market Cap: 12.83M Prev closed: 3.48 Open: 3.7 High: 3.75 Low: 3.32 52 week low: 3.04 52 week high: 10.63 Dividends: No Dividends Next ER: February 27, 2023 Before Market Opens
Company Profile InMed is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (CBN), in diseases with high unmet medical need. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs.
Earnings History Date EPS / Forecast Revenue / Forecast May 11, 2023 February 17, 2023 -0.91 / -4.5469.78K / 500KNovember 11, 2022 -4.06 / -4.25320.79K / 500KSeptember 23, 2022 -12.22 / -0.29514.8K / 0.97MBeat! May 13, 2022 -0.25 / -0.25309.59K / 309.59Kview more
Historical Data Date Price Open High Low Vol Change ER May 19, 2022 0.790 0.770 0.850
0.770
14.52K 1.28% May 18, 2022 0.780 0.840 0.890
0.768
95.87K -6.04% May 17, 2022 0.830 0.785 0.890
0.770
54.48K 3.76% May 16, 2022 0.800 0.795 0.810
0.780
47.84K -3.61% May 13, 2022 0.830 0.880 0.890
0.800
62.33K 2.47% May 12, 2022 0.810 0.797 0.890
0.795
91.17K -1.22% May 11, 2022 0.820 0.860 0.865
0.767
92.15K -5.21% May 10, 2022 0.865 0.822 0.947
0.800
53.79K 8.49% May 9, 2022 0.797 0.910 0.990
0.780
95.17K -15.16% May 6, 2022 0.940 0.850 0.965
0.850
55.85K 5.25% view more
NASDAQ - Nasdaq Stock Market
News
Prothena, bioAffinity top healthcare gainers; Mind Medicine, Gamida lead losers' pack seekingalpha.com Sep 28, 2022 10:02 pm InMed Pharmaceuticals GAAP EPS of -$33.17, revenue of $1.09M seekingalpha.com Sep 26, 2022 1:53 pm InMed Pharma announces $6M private placement seekingalpha.com Sep 10, 2022 5:20 am InMed climbs 23% amid plans to focus on pharma drug development seekingalpha.com Sep 9, 2022 7:10 pm InMed Pharmaceuticals sinks 16% over consolidating 1 for 25 shares to meet listing requirements seekingalpha.com Aug 24, 2022 5:54 am InMed Pharma says phase 2 trial for skin disorder cannabinol cream can now include teens seekingalpha.com Jul 25, 2022 9:01 pm InMed names new COO seekingalpha.com Jul 18, 2022 7:35 pm InMed Pharmaceuticals gets non-compliance notice on Nasdaq minimum bid price requirement seekingalpha.com Jul 13, 2022 3:08 pm InMed says peer-reviewed study highlights potential role of rare cannabinoids THCV, CBC on skin conditions seekingalpha.com Jun 14, 2022 10:05 pm InMed begins B2B sales of cannabinoid THCV seekingalpha.com Jun 9, 2022 8:56 pm InMed Pharmaceuticals announces $5M registered direct and private placement offerings seekingalpha.com Jun 2, 2022 8:10 pm InMed launches sale of cannabidivarin in U.S. seekingalpha.com Apr 22, 2022 12:13 am InMed CFO steps down, interim CFO appointed seekingalpha.com Mar 17, 2022 7:57 pm InMed Pharmaceuticals GAAP EPS of -$0.31, revenue of $0.27M seekingalpha.com Feb 15, 2022 4:06 pm InMed launches B2B sales of rare cannabinoid cannabicitran seekingalpha.com Jan 20, 2022 1:11 am InMed Pharma soars after releasing extracts from research report seekingalpha.com Nov 18, 2021 12:26 am InMed Pharmaceuticals reports FQ1 results seekingalpha.com Nov 10, 2021 10:03 pm InMed files PCT patent application for treating neurodegenerative disease seekingalpha.com Nov 3, 2021 7:51 pm InMed shares jump 8% after completing BayMedica deal seekingalpha.com Oct 14, 2021 4:38 am InMed Pharmaceuticals commences mid-stage INM-755 Epidermolysis Bullosa trial seekingalpha.com Sep 30, 2021 7:42 pm This company doesn't provide a dividend.
Key Persons CEO : Eric A. Adams (16 Jun 2016–) Talk about InMed Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
investors.inmedpharma.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet